Bluejay Diagnostics (BJDX) Return on Capital Employed (2021 - 2026)

Bluejay Diagnostics has disclosed Return on Capital Employed across 6 years of filings, most recently posting 141.62% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 141.62%, up 94.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 141.62% (up 94.0% YoY), and the FY2025 annual result was 120.52%, up 2424.0% from the prior year.
• Return on Capital Employed came in at 141.62% for Q1 2026 at Bluejay Diagnostics, roughly flat from 142.32% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 26.33% in Q1 2022 to a low of 291.92% in Q1 2024.
• The 5-year median for Return on Capital Employed is 140.02% (2025), against an average of 128.64%.
• Across the five-year window, Return on Capital Employed sank 19985 bps in 2024 and soared 14936 bps in 2025, its largest moves.
• Bluejay Diagnostics' Return on Capital Employed stood at 71.82% in 2022, then tumbled by 200 bps to 215.44% in 2023, then jumped by 50 bps to 107.09% in 2024, then tumbled by 33 bps to 142.32% in 2025, then climbed by 0 bps to 141.62% in 2026.
• The last three Return on Capital Employed figures came in at 141.62% (Q1 2026), 142.32% (Q4 2025), and 155.09% (Q3 2025), per Business Quant data.